These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26377152)

  • 41. Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation.
    Drouot X; Oshino S; Jarraya B; Besret L; Kishima H; Remy P; Dauguet J; Lefaucheur JP; Dollé F; Condé F; Bottlaender M; Peschanski M; Kéravel Y; Hantraye P; Palfi S
    Neuron; 2004 Dec; 44(5):769-78. PubMed ID: 15572109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Default mode network hypometabolism in epileptic encephalopathies with CSWS.
    Ligot N; Archambaud F; Trotta N; Goldman S; Van Bogaert P; Chiron C; De Tiège X
    Epilepsy Res; 2014 Jul; 108(5):861-71. PubMed ID: 24746674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
    Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolism.
    Georgiou MF; Gonenc A; Waldrop-Valverde D; Kuker RA; Ezuddin SH; Sfakianakis GN; Kumar M
    J Nucl Med; 2008 Dec; 49(12):1999-2005. PubMed ID: 18997046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.
    Feigin A; Leenders KL; Moeller JR; Missimer J; Kuenig G; Spetsieris P; Antonini A; Eidelberg D
    J Nucl Med; 2001 Nov; 42(11):1591-5. PubMed ID: 11696626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cerebral glucose metabolism in autistic children. Study and positron emission tomography].
    De Volder AG; Bol A; Michel C; Cogneau M; Goffinet AM
    Acta Neurol Belg; 1988; 88(2):75-90. PubMed ID: 3260437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of EEG-vigilance on brain glucose uptake measured with [(18)F]FDG and PET in patients with depressive episode or mild cognitive impairment.
    Guenther T; Schönknecht P; Becker G; Olbrich S; Sander C; Hesse S; Meyer PM; Luthardt J; Hegerl U; Sabri O
    Neuroimage; 2011 May; 56(1):93-101. PubMed ID: 21276863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
    Zhao P; Zhang B; Gao S
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S60-2. PubMed ID: 22166456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pilot study of positron emission tomography (PET) brain glucose metabolism to assess the efficacy of tongue and body acupuncture in cerebral palsy.
    Wong VC; Sun JG; Yeung DW
    J Child Neurol; 2006 Jun; 21(6):456-62. PubMed ID: 16948928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Why glucose transport in the brain matters for PET.
    Barros LF; Porras OH; Bittner CX
    Trends Neurosci; 2005 Mar; 28(3):117-9. PubMed ID: 15749163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([¹⁸F]AV-133) in a MPTP-lesioned PD mouse model.
    Chao KT; Tsao HH; Weng YH; Hsiao IT; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lin KJ
    Synapse; 2012 Sep; 66(9):823-31. PubMed ID: 22623146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
    Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
    Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [18F]FDG-PET as an imaging biomarker to NMDA receptor antagonist-induced neurotoxicity.
    Shirakawa T; Mitsuoka K; Kuroda K; Miyoshi S; Shiraki K; Naraoka H; Noda A; Fujikawa A; Fujiwara M
    Toxicol Sci; 2013 May; 133(1):13-21. PubMed ID: 23457119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal metabolic networks in atypical parkinsonism.
    Eckert T; Tang C; Ma Y; Brown N; Lin T; Frucht S; Feigin A; Eidelberg D
    Mov Disord; 2008 Apr; 23(5):727-33. PubMed ID: 18186116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Developmental changes in brain metabolism in sedated rhesus macaques and vervet monkeys revealed by positron emission tomography.
    Jacobs B; Chugani HT; Allada V; Chen S; Phelps ME; Pollack DB; Raleigh MJ
    Cereb Cortex; 1995; 5(3):222-33. PubMed ID: 7613078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cortical areas involved in behavioral expression of external pallidum dysfunctions: A PET imaging study in non-human primates.
    Galineau L; Kas A; Worbe Y; Chaigneau M; Herard AS; Guillermier M; Delzescaux T; Féger J; Hantraye P; Tremblay L
    Neuroimage; 2017 Feb; 146():1025-1037. PubMed ID: 27989846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of abnormal glucose metabolism associated with Parkinson's disease in Chinese participants based on 18F-fluorodeoxyglucose positron emission tomography imaging.
    Jin R; Ge J; Wu P; Lu J; Zhang H; Wang J; Wu J; Han X; Zhang W; Zuo C
    Neuropsychiatr Dis Treat; 2018; 14():1981-1989. PubMed ID: 30122931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain glucose metabolism changes in Parkinson's disease patients with CHCHD2 mutation based on (18)F-FDG PET imaging.
    Mao CY; Wu P; Zhang SY; Yang J; Liu YT; Zuo CT; Zhuang ZP; Shi CH; Xu YM
    J Neurol Sci; 2016 Oct; 369():303-305. PubMed ID: 27653913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.